Top Markets
#1 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.57%
#2 Movement Movement +8.01%
#3 COTI COTI +7.56%
#4 DMT-NAT DMT-NAT +7.27%
#5 Victoria VR Victoria VR +7.18%
#6 GRVT Token GRVT Token +4.67%
#7 Cryptopia Cryptopia +3.74%
#8 Kinetiq Kinetiq +3.53%
#9 Lisk Lisk +3.28%
#10 Jito Jito +3.02%
Coin of the day
FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock)
Configuración
Idioma
ESPAñOL
Moneda
USD
Tema
NewCardio, Inc. NewCardio, Inc.

NewCardio, Inc.

NWCI
Clasificación en acciones #42209
NewCardio, Inc. is a company dedicated to cardiac diagnostics and related... NewCardio, Inc. is a company dedicated to cardiac diagnostics and related services. Its primary objective is the research, creation, and market introduction of exclusive software platform technologies. These innovations are designed for two main applications: the non-invasive diagnosis and continuous monitoring of cardiovascular diseases (CVD), and the assessment of cardiac safety for experimental drugs. The company's underlying technology analyzes the heart's electrical activity in real-time and in three dimensions, using data gathered from the body's surface via standard 12-lead electrocardiogram (ECG) electrodes. NewCardio is also actively developing several products. QTinno, for instance, is an automated solution for cardiac safety, utilizing algorithms to automatically measure, analyze, and report on collected ECGs, thereby streamlining traditional manual or semi-automated methods. Another product, CardioBip, is a mobile ECG system for remote transmission, comprising a portable recording and transmitting device along with web-based software that receives, processes, and interprets the data. Furthermore, the company is progressing with my3KG, a software application intended to provide a comprehensive method for evaluating cardiac electrical activity across both time and space. NewCardio, Inc. was founded in 2004 and is headquartered in Branchburg, New Jersey.
Precio por acción
$0.0001
Última sincronización: 2026-08-11
Capitalización bursátil
$3.32K
Cambio (1 día)
0.00%
Cambio (1 año)
0.00%
País
US
Comercio NewCardio, Inc. (NWCI)

Categoría

Healthcare
Ingresos de NewCardio, Inc. (NWCI)
Ingresos en Aug 2026 TTM: 0
Según los últimos informes financieros de NewCardio, Inc., los ingresos actuales de la empresa (TTM) son 0. En 2026, la empresa obtuvo unos ingresos de 0 igual a los ingresos del año 2026, que fueron de 0. Los ingresos representan la cantidad total que una empresa genera por la venta de bienes o servicios. A diferencia de las ganancias, no se restan los gastos.
Historial de ingresos de NewCardio, Inc. desde 2026 hasta 2026
Ingresos al final de cada año
Año Ingresos Cambiar
Not enough data for the provided dates.
Ingresos de empresas similares o competidoras
Empresa Ingresos Diferencia de ingresos País
Abbott Laboratories Abbott Laboratories
Abbott Laboratories
ABT.US
 $46.59B -
US
Stryker Corporation Stryker Corporation
Stryker Corporation
SYK.US
 $25.84B -
US
Medtronic plc Medtronic plc
Medtronic plc
MDT.US
 $35.48B -
IE
Boston Scientific Corporation Boston Scientific Corporation
Boston Scientific Corporation
BSX.US
 $21.00B -
US
Edwards Lifesciences Corporation Edwards Lifesciences Corporation
Edwards Lifesciences Corporation
EW.US
 $6.51B -
US